Targeted lung cancer screening selects individuals at high risk of cardiovascular disease

•93% participants at high risk of cardiovascular disease (CVD) (QRISK2 score ≥10%).•1 in 3 of all screening attendees at high risk of CVD but not taking a statin.•Those screened had double the CVD risk than controls (21.1% vs. 10.3%, p 

Saved in:
Bibliographic Details
Published in:Lung cancer (Amsterdam, Netherlands) Netherlands), 2018-10, Vol.124, p.148-153
Main Authors: Balata, H., Blandin Knight, S., Barber, P., Colligan, D., Crosbie, E.J., Duerden, R., Elton, P., Evison, M., Greaves, M., Howells, J., Irion, K., Karunaratne, D., Kirwan, M., Macnab, A., Mellor, S., Miller, C., Newton, T., Novasio, J., Sawyer, R., Sharman, A., Slevin, K., Smith, E., Taylor, B., Taylor, S., Tonge, J., Walsham, A., Waplington, S., Whittaker, J., Booton, R., Crosbie, P.A.J.
Format: Article
Language:English
Subjects:
Aged
Calcinosis
Cardiovascular Diseases - diagnosis
Cardiovascular Diseases - epidemiology
Cardiovascular risk
Community based
Early Detection of Cancer - methods
England - epidemiology
Female
Humans
Lung cancer screening
Lung Neoplasms - diagnosis
Lung Neoplasms - epidemiology
Male
Middle Aged
QRISK
Risk
Risk Assessment
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•93% participants at high risk of cardiovascular disease (CVD) (QRISK2 score ≥10%).•1 in 3 of all screening attendees at high risk of CVD but not taking a statin.•Those screened had double the CVD risk than controls (21.1% vs. 10.3%, p 
ISSN:0169-5002
1872-8332
DOI:10.1016/j.lungcan.2018.08.006